CARRARO, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 4.941
EU - Europa 2.386
AS - Asia 974
SA - Sud America 44
Continente sconosciuto - Info sul continente non disponibili 9
AF - Africa 5
OC - Oceania 4
Totale 8.363
Nazione #
US - Stati Uniti d'America 4.934
PL - Polonia 531
SE - Svezia 506
UA - Ucraina 401
SG - Singapore 284
CN - Cina 281
IT - Italia 277
HK - Hong Kong 199
TR - Turchia 159
FI - Finlandia 120
GB - Regno Unito 88
RU - Federazione Russa 88
DE - Germania 77
CH - Svizzera 66
IE - Irlanda 64
BG - Bulgaria 63
FR - Francia 39
BR - Brasile 34
NL - Olanda 26
BE - Belgio 16
IL - Israele 16
IN - India 12
EU - Europa 8
VN - Vietnam 6
AT - Austria 5
ES - Italia 5
CA - Canada 4
JP - Giappone 4
AU - Australia 3
PE - Perù 3
SN - Senegal 3
AL - Albania 2
AR - Argentina 2
AZ - Azerbaigian 2
EC - Ecuador 2
HU - Ungheria 2
MA - Marocco 2
PA - Panama 2
RO - Romania 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
GR - Grecia 1
HR - Croazia 1
IR - Iran 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 8.363
Città #
Fairfield 627
Woodbridge 562
Warsaw 528
Houston 515
Ann Arbor 435
Chandler 355
Jacksonville 353
Ashburn 329
Wilmington 293
Seattle 261
Cambridge 222
Hong Kong 198
Izmir 151
Singapore 134
Princeton 125
Boardman 105
Beijing 77
Trieste 73
Bern 65
Columbus 64
Dublin 64
Sofia 63
Moscow 50
Düsseldorf 46
San Diego 43
Dearborn 42
Milan 27
The Dalles 21
Verona 17
Brussels 16
Des Moines 16
Tel Aviv 16
Chicago 15
Rome 15
Hefei 14
Los Angeles 14
Nanjing 14
Washington 14
Fremont 13
Norwalk 13
Phoenix 12
Falls Church 11
Guangzhou 10
Auburn Hills 9
Munich 9
Shanghai 9
Dallas 8
Santa Clara 7
Buffalo 6
Dong Ket 6
Frankfurt am Main 6
Fuzhou 6
Kunming 6
Hebei 5
Jinan 5
Nanchang 5
Pune 5
Shenyang 5
Grafing 4
Madrid 4
Mestre 4
Atatürk 3
Bremen 3
Campoformido 3
Dakar 3
Edinburgh 3
Helsinki 3
Mcallen 3
Shenzhen 3
São Paulo 3
Wuxi 3
Atlanta 2
Baku 2
Baotou 2
Bussero 2
Busto Arsizio 2
Centro 2
Changchun 2
Chengdu 2
Council Bluffs 2
Dongguan 2
Glasgow 2
Harbin 2
Istanbul 2
Jiaxing 2
Lima 2
Mogliano Veneto 2
Mumbai 2
New York 2
Newark 2
North Bergen 2
Padova 2
Panama City 2
Pistoia 2
Sacile 2
Saint Petersburg 2
San Vito al Tagliamento 2
Sonepat 2
Trento 2
Vienna 2
Totale 6.235
Nome #
The renal phenotype of allopurinol-treated HPRT-deficient mouse 411
A nanoporous surface is essential for glomerular podocyte differentiation in three-dimensional culture. 362
Albumin permeability in isolated glomeruli in incipient experimental diabetes mellitus. 251
Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS 249
Direct effect of plasma permeability factors from patients with idiopatic FSGS on nephrin and podocin expression in human podocytes. 211
Relationship between whole-body protein turnover and serum creatinine in chronically uremic patients. 188
Podocyte expression of membrane transporters involved in puromycin aminonucleoside-mediated injury. 186
Hemicentin 1 influences podocyte dynamic changes in glomerular diseases 178
Characterization of nucleic acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices 176
Glomerular permeability defect in hypertension is dependent on renin angiotensin system activation. 170
The effect of proteinase inhibitors on glomerular albumin permeability induced in vitro by serum from patients with idiopathic focal segmental glomerulosclerosis. 167
Podocyte developmental defects caused by adriamycin in zebrafish embryos and larvae: a novel model of glomerular damage. 165
Rapid and cost-effective xenograft hepatocellular carcinoma model in Zebrafish for drug testing 165
Circulating anti-actin and anti-ATP synthase antibodies identify a sub-set of patients with idiopathic nephrotic syndrome. 162
Design and fabrication of large area nano-structured substrates for use in pancreatic beta-cell engineering 156
Role of components of frailty on quality of life in dialysis patients: a cross-sectional study. 154
Posttransplant recurrence of proteinuria in a case of focal segmental glomerulosclerosis associated with WT1 mutation 149
Mechanisms of malnutrition in uremia. 146
Recurrent focal glomerulosclerosis in the era of genetics of podocyte proteins: theory and therapy. 141
Characterisation of nucleid acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices 138
Effects of a dimeric vs a monomeric nonionic contrast medium on renal function in patients with mild to moderate renal insufficiency: a double-blind, randomized clinical trial 137
Evaluation of dietary compliance in patients with chronic renal failure on conservative treatment: comparison of methods to assess dietary intake 135
null 130
The assessment of nutritional status in chronically uremic patients 130
Apolipoprotein E in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. 128
Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. 125
Proteomics of plasma and urine in primary nephrotic syndrome in children. 125
Contrast agent nephrotoxicity: comparison of ionic and nonionic contrast agents 124
Prospective and sequential study to establish the efficacy of rituximab therapy in maintaining remission of nephritic syndrome in patients with nephropathy at minimal injury or steroid-dependent, recurrent focal segmental glomerulosclerosis (NEMO) | Studio prospettico e sequenziale per stabilire l'efficacia della terapia con rituximab nel mantenere la remissione della sindrome nefrosica in pazienti con nefropatia a lesioni minime o glomerulosclerosi focale steroido-dipendenti o recidivanti (NEMO) 124
null 124
Involvement of the renin angiotensin system in the pathogenesis of postexercise proteinuria 123
Transitions of serum albumin in patients with glomerulosclerosis 'in vivo' characterization by electrophoretic titration curves. 122
Recurrent autosomal-dominant focal segmental glomerulosclerosis 122
Dose effect of nitrendipine on urinary enzymes and microproteins following non-ionic radiocontrast administration. 121
Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome 119
Nephrotic urine prevents increased rat glomerular albumin permeability induced by serum from the same patient with idiopathic nephrotic syndrome 119
HIV-1 Tat reduces nephrin in human podocytes: a potential mechanism for enhanced glomerular permeability in HIV-associated nephropathy 119
Proteinuria in focal segmental glomerulosclerosis: role of circulating factors and therapeutic approach 116
Contrast media nephrotoxicity: urinary protein and enzyme pattern in patients with or without saline infusion during digital subtracting angiography. 114
Podocyte glutamatergic signaling contributes to the function of the glomerular filtration barrier 114
Exercise-induced proteinuria. 113
Permeability plasma factors in nephrotic syndrome: more than one factor, more than one inhibitor. 108
Inhibition of renal permeability towards albumin: a new function of apolipoproteins with possible pathogenetic relevance in focal glomerulosclerosis. 108
The role of kidney biopsy in the diagnosis of renal disease and renal masses 108
Apolipoproteins prevent glomerular albumin permeability induced in vitro by serum from patients with focal segmental glomerulosclerosis 102
Characterization of plasma factor that alter albumin permeability in isolated glomeruli 101
Humoral permeability factors in the nephrotic syndrome: a compendium and prospectus. 99
Nifedipine reduces postexercise proteinuria in young volunteers. 98
Apheresis in primary focal segmental glomerulosclerosis of native and transplanted kidneys: a therapeutic protocol. 95
A clinical case. Primary renal amyloidosis 90
SNOM fluorescence techniques applied to cytoskeleton study in cell cultures 89
Captopril in the treatment of arterial hypertension. Studies of the therapeutic effectiveness and the alleged nephrotoxicity of the drug 87
Nutritional state in patients on long-term low-protein diet or with nephrotic syndrome. 86
A comparison between an ionic paramagnetic contrast agent (Gd-DTPA) and a nonionic one (Gd-DTPA-BMA) in functional kidney evaluation with magnetic resonance 84
An atypical presentation of a case of Horton's giant-cell arteritis 79
The pathogenetical mechanism of glomerular proteinuria 79
Extracorporeal photochemotherapy for the treatment of glomerulopathies with associated nephrotic syndrome. 76
Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. 74
Prophylactic perioperative plasmapheresis does not prevent rebound of permeability factors in patients with focal segmental glomerulosclerosis (FSGS) who undergo kidney transplant 70
Churg-Strauss vasculitis. A clinical case 70
Paraneoplastic syndromes and the kidney 69
null 67
Glomerular albumin permeability as an in vitro model for characterizing the mechanism of focal glomerulosclerosis and predicting post-transplant recurrence. 53
Small molecule membrane transporters in the mammalian podocyte: a pathogenic and therapeutic target 53
Warfarin-related nephropathy: possible role for the warfarin pharmacogenetic profile 34
Totale 8.488
Categoria #
all - tutte 23.836
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.836


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020218 0 0 0 0 0 0 0 0 0 71 105 42
2020/20211.244 98 79 151 160 123 117 74 95 53 122 58 114
2021/2022710 28 47 74 87 16 66 29 28 84 75 60 116
2022/2023983 91 109 87 133 111 190 1 84 101 12 56 8
2023/2024545 92 42 27 61 51 41 81 94 3 3 31 19
2024/2025805 14 11 41 142 124 177 43 61 132 60 0 0
Totale 8.488